71 related articles for article (PubMed ID: 10928123)
1. Absence of mutations in the NBS1 gene in B-cell malignant lymphoma patients.
Hama S; Matsuura S; Tauchi H; Sawada J; Kato C; Yamasaki F; Yoshioka H; Sugiyama K; Arita K; Kurisu K; Kamada N; Heike Y; Komatsu K
Anticancer Res; 2000; 20(3B):1897-900. PubMed ID: 10928123
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the Nijmegen breakage syndrome gene in medulloblastomas.
Huang J; Grotzer MA; Watanabe T; Hewer E; Pietsch T; Rutkowski S; Ohgaki H
Clin Cancer Res; 2008 Jul; 14(13):4053-8. PubMed ID: 18593981
[TBL] [Abstract][Full Text] [Related]
3. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.
Watanabe T; Nobusawa S; Lu S; Huang J; Mittelbronn M; Ohgaki H
J Neuropathol Exp Neurol; 2009 Feb; 68(2):210-5. PubMed ID: 19151620
[TBL] [Abstract][Full Text] [Related]
4. Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation.
Gładkowska-Dura M; Dzierzanowska-Fangrat K; Dura WT; van Krieken JH; Chrzanowska KH; van Dongen JJ; Langerak AW
J Pathol; 2008 Nov; 216(3):337-44. PubMed ID: 18788073
[TBL] [Abstract][Full Text] [Related]
5. Nijmegen breakage syndrome gene (NBS1) is not the tumor suppressor gene at 8q21.3 involved in colorectal carcinoma.
Varon R; Gosse-Brun S; Bignon YJ; Sperling K; Uhrhammer N
Oncol Rep; 2002; 9(4):709-11. PubMed ID: 12066197
[TBL] [Abstract][Full Text] [Related]
6. Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma.
Cerosaletti KM; Morrison VA; Sabath DE; Willerford DM; Concannon P
Genes Chromosomes Cancer; 2002 Nov; 35(3):282-6. PubMed ID: 12353271
[TBL] [Abstract][Full Text] [Related]
7. Nijmegen breakage syndrome in 13% of age-matched Czech children with primary microcephaly.
Seeman P; Gebertová K; Paderová K; Sperling K; Seemanová E
Pediatr Neurol; 2004 Mar; 30(3):195-200. PubMed ID: 15033202
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL).
Varon R; Reis A; Henze G; von Einsiedel HG; Sperling K; Seeger K
Cancer Res; 2001 May; 61(9):3570-2. PubMed ID: 11325820
[TBL] [Abstract][Full Text] [Related]
9. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
[TBL] [Abstract][Full Text] [Related]
10. No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours.
Koch A; Waha A; Hartmann W; Milde U; Goodyer CG; Sörensen N; Berthold F; Digon-Söntgerath B; Krätzschmar J; Wiestler OD; Pietsch T
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):532-9. PubMed ID: 15488029
[TBL] [Abstract][Full Text] [Related]
11. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
Roznowski K; Januszkiewicz-Lewandowska D; Mosor M; Pernak M; Litwiniuk M; Nowak J
Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
[TBL] [Abstract][Full Text] [Related]
12. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
13. Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein.
Krüger L; Demuth I; Neitzel H; Varon R; Sperling K; Chrzanowska KH; Seemanova E; Digweed M
Carcinogenesis; 2007 Jan; 28(1):107-11. PubMed ID: 16840438
[TBL] [Abstract][Full Text] [Related]
14. Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks.
Digweed M; Sperling K
DNA Repair (Amst); 2004; 3(8-9):1207-17. PubMed ID: 15279809
[TBL] [Abstract][Full Text] [Related]
15. Positional cloning and functional analysis of the gene responsible for Nijmegen breakage syndrome, NBS1.
Tauchi H
J Radiat Res; 2000 Mar; 41(1):9-17. PubMed ID: 10838806
[TBL] [Abstract][Full Text] [Related]
16. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
17. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms and haplotypes of the NBS1 gene in childhood acute leukaemia.
Mosor M; Ziółkowska I; Januszkiewicz-Lewandowska D; Nowak J
Eur J Cancer; 2008 Oct; 44(15):2226-32. PubMed ID: 18691878
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the BIK gene in human peripheral B-cell lymphomas.
Arena V; Martini M; Luongo M; Capelli A; Larocca LM
Genes Chromosomes Cancer; 2003 Sep; 38(1):91-6. PubMed ID: 12874789
[TBL] [Abstract][Full Text] [Related]
20. Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies.
Nakatsuka S; Liu A; Yao M; Takakuwa T; Tomita Y; Hoshida Y; Nishiu M; Aozasa K
Int J Oncol; 2003 Mar; 22(3):561-8. PubMed ID: 12579309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
